 |
Learn About Cancer Clinical Trials
An Overview of the Cooperative Group System
The vast majority of cancer research conducted in the United
States is carried out in cancer centers, cancer cooperative groups, and
community clinical oncology programs. Cancer cooperative groups are networks of
investigators and institutions located in academic centers and the community
that work together to conduct clinical cancer research. More than half of the
cancer clinical trials currently underway are being conducted by cancer
cooperative groups.
The cooperative group system, together with the work of cancer
centers throughout the United States, has a history of discovery and
development that is longer-lived and more successful than any other in cancer
research or medicine.
Since its beginnings in the 1950s, the cancer cooperative group
system has produced a number of major advances in cancer clinical care. These advances
have been possible only because of the contribution of the more than 500,000
patients who have been treated in the cooperative group framework of quality
control and quality assurance.
For instance, evidence and knowledge gained from cancer cooperative
group trials:
-
Resulted in long-term survival and cures in the majority of
pediatric cancer cases.
-
Established the efficacy of less-invasive treatments for
breast cancer, such as lumpectomy and chemotherapy, resulting in reduced use of
radical mastectomy.
-
Established Taxol as a premier treatment for ovarian cancer
and metastatic non-small cell lung cancer.
-
Demonstrated treatment using alpha 2b interferon as the
first, and currently only, effective adjuvant treatment for melanoma.
-
Showed that chemotherapy combined with radiation therapy
significantly increased three and seven year survival in non-small cell lung
cancer.
-
Established combined chemotherapy and radiation as the most
effective treatment of advanced cervical cancer.
Activities in the cancer cooperative groups are largely funded as
federal programs through the National Cancer Institute (NCI), one of 25
institutes and centers in the National Institutes of Health.
The modern cooperative groups trace their beginning to the
mid-1950s, when a small group of hospitals along the East Coast banded together
to conduct collaborative research on childhood acute leukemia. The system
proved to be such a successful platform that it was adopted by the NCI.
More than 1500 institutions and thousands of professionals
participate in cancer cooperative group trials and activities. Together these members
enroll more than 20,000 patients on cancer clinical trials each year and
account for approximately 60 percent of all patients enrolled each year in
cancer clinical trials in the United States.
In 1998, seven of the cooperative groups established the
Coalition of Cancer Cooperative Groups, Inc., to coordinate efforts to expand
the enrollment of patients in trials. To download a more comprehensive
discussion of the background, history, and organization of the cooperative
groups, click here*.
*This file is an Adobe Acrobat file. If you do not have the Adobe
Acrobat Reader installed on your computer, you can download it free of charge
from Adobe.
|
 |
|